---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-035861"
form_type: "8-K"
ticker: "INBS"
cik: "0001725430"
company_name: "INTELLIGENT BIO SOLUTIONS INC."
filed_at: "2026-08-03T21:22:39+00:00"
generated_at: "2026-08-03T21:24:20.736595+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# INBS completes interference study; on track for 510(k) submission in H2 2026

## Summary
- Completed Interference Study for fingerprint drug screening system, testing common substances (hand creams, alcohol, oils, dirt, water) for impact on codeine detection.
- Study conducted with CenExel Clinical Research, following FDA guidance and ICH GCP guidelines; data analysis underway with LC-MS/MS verification.
- Company remains on track to submit FDA 510(k) package in calendar H2 2026 for U.S. market clearance for opiate codeine detection.
- Part of comprehensive program including Cut-off Study, Method Comparison Study, precision and penetration testing.

## SEC filing metadata
- accession: 0001493152-26-035861
- form_type: 8-K
- ticker: INBS
- cik: 0001725430
- company_name: INTELLIGENT BIO SOLUTIONS INC.
- filed_at: 2026-08-03T21:22:39+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1725430/000149315226035861/0001493152-26-035861-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1725430/000149315226035861/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-035861
- JSON: https://secwatch.observer/filing/0001493152-26-035861.json
- Plain text: https://secwatch.observer/filing/0001493152-26-035861.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.